# The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment

> **NCT07140965** · — · SUSPENDED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 175 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Pegulicianine Fluorescence-Guided Surgery
- **PROCEDURE:** Digital Breast Tomosynthesis
- **PROCEDURE:** Breast Conserving Therapy

## Key facts

- **NCT ID:** NCT07140965
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2025-10-09
- **Primary completion:** 2027-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 175 (ESTIMATED)
- **Why stopped:** PI Request
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07140965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07140965, "The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07140965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*